An investigation of cut-points for primary breast cancer oestrogen and progesterone receptor assays
- 1 March 1996
- journal article
- Published by Elsevier in The Journal of Steroid Biochemistry and Molecular Biology
- Vol. 57 (5-6) , 323-328
- https://doi.org/10.1016/0960-0760(95)00275-8
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- The standardization of estrogen receptorsThe Journal of Steroid Biochemistry and Molecular Biology, 1993
- Evidence for bimodal distribution of breast carcinoma ER and PgR values quantitated by enzyme immunoassayEuropean Journal Of Cancer, 1993
- Evolution of immunoreactivity of monoclonal antibodies H222 and/or D547 used in the detection of breast cancer estrogen receptors. Varying reactivity of receptor isoformsThe Journal of Steroid Biochemistry and Molecular Biology, 1991
- Inter-laboratory quality control of estrogen and progesterone receptor assays in breast cancer tissue using lyophilised cytosolsClinical Biochemistry, 1985
- STEROID-HORMONE RECEPTORS AND SURVIVAL AFTER FIRST RELAPSE IN BREAST CANCERThe Lancet, 1984
- Progesterone Receptors as a Prognostic Factor in Stage II Breast CancerNew England Journal of Medicine, 1983
- Steroid receptors and prognosis in operable (stage I and II) breast cancerEuropean Journal of Cancer and Clinical Oncology, 1983
- Relationship between primary breast tumor receptor status and patient survivalCancer, 1980
- The relative importance of estrogen receptor analysis as a prognostic factor for recurrence or response to chemotherapy in women with breast cancerCancer, 1980
- ŒSTROGEN RECEPTORS AND PROGNOSIS IN EARLY BREAST CANCERThe Lancet, 1979